Scientists apply optical pooled CRISPR screening to identify potential new Ebola drug targets
On Jul. 24, 2025, researchers at the Broad Institute and the National Emerging Infectious Diseases Laboratories (NEIDL) at…
-
-
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Pharmaceutical | Therapeutics | Vaccine
AstraZeneca plans to invest $50 billion in America for medicines manufacturing and R&D
On Jul. 22, 2025, AstraZeneca announces $50 billion of investment in the United States by 2030, building on…
-
Biogen Announces $2 Billion Manufacturing Investment in North Carolina’s Research Triangle Park
On Jul. 21, 2025, Biogen announced it intends to invest an additional $2 billion in its existing manufacturing…
-
Waters to buy Becton unit in a $17.5 billion deal amid tariff pressures
On Jul. 14, 2025, Lab equipment maker Waters Corp said it will buy a bioscience and diagnostics unit…
-
Scientists discover compounds that help cells fight a wide range of viruses
On Jul. 14, 2025, Researchers at MIT and other institutions have identified compounds that can fight off viral…
-
A bionic knee integrated into tissue can restore natural movement
On Jul. 10, 2025, MIT researchers announced they have developed a new bionic knee that can help people…
-
Implantable device could save diabetes patients from dangerously low blood sugar
On Jul. 9, 2025, MIT engineers announced they have designed an implantable reservoir that can remain under the…
-
KalVista Pharmaceuticals Announces FDA Approval of EKTERLY® (sebetralstat), First and Only Oral On-demand Treatment for Hereditary Angioedema
On Jul. 7, 2025, KalVista Pharmaceuticals announced that the U.S. Food and Drug Administration(FDA) has approved EKTERLY® (sebetralstat),…
-
Biotechnology | COVID-19 | HIV | Infectious Disease | Influenza | Measles | Polio | Vaccine
Amid multi-state measles outbreak, Poll Shows 79% of Americans support routine childhood vaccine requirements
On Jun. 25, 2025, in the midst of a multi-state measles outbreak, a poll by Harvard T.H. Chan…
-
Vertex Reports Positive Data for Zimislecel in Type 1 Diabetes
On Jun. 20, 2025, Vertex Pharmaceuticals announced publication of updated data from the Phase 1/2 portion of the…
-
Lilly to acquire Verve Therapeutics for $1 billion to advance one-time treatments for people with high cardiovascular risk
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
-
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59
On Jun. 12, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345),…
-
Sanofi to acquire Blueprint Medicines for $9.1 Billion
On Jun. 2, 2025, Sanofi and Blueprint Medicines, a US-based, publicly traded biopharmaceutical company specializing in systemic mastocytosis…
-
HHS terminated award for Moderna’s pre-pandemic influenza vaccines
On May 28, 2025, Moderna announced that it has received notice from the U.S. Department of Health and…
-
COVID-19 | Disease | Environmental | Infectious Disease | Influenza | Measles | Oncology | Vaccine
U.S. excess deaths continued to rise even after the COVID-19 pandemic
On May 23, 2025 a Boston University School of Public Health (BUSPH) led study revealed that there were…
-
Prime Medicine Announces Breakthrough Data Showing Rapid Restoration of DHR Positivity After Single Infusion of PM359, an Investigational Prime Editor for Chronic Granulomatous Disease
On May 19, 2025, Prime Medicine announced positive initial data from the first patient dosed in its ongoing…
-
New study aims to uncover the genetics of anorexia and other eating disorders
On May 19, 2025, researchers at the Broad Institute Ben Neale and Mark Daly are co-leading the study,…
-
Scientists complete largest wiring diagram and functional map of the brain to date
On Apr. 9, 2025, a team of neuro scientists scientists published findings from the Machine Intelligence from Cortical…
-
Biotechnology | CRISPR | Disease | Genomics | Oncology | Therapeutics
Novel genomic screening tool enables precision reverse-engineering of genetic programming in cells
On Apr. 3, 2025, a collaborative research led by investigators at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center…
-
Beam Therapeutics Announces Positive Data in Trial Demonstrating First Ever Clinical Genetic Correction of a Disease-causing Mutation
On Mar. 10, 2025, Beam Therapeutics announced initial safety and efficacy data from its Phase 1/2 trial of…
-
Revvity’s EUROIMMUN Receives CE Mark for Novel Measles Antibody Detection Assay
On Mar. 3, 2025, Revvity announced the launch of EUROIMMUN’s CE-marked Anti-Measles Virus ELISA 2.0 (IgG) to support…
-
AquaBounty Announced Plans to Cease Fish Farming Operations
On Dec. 11, 2024 the Board of Directors of AquaBounty Technologies announced that the Company was winding down…
-
Boston Scientific closes acquisition of Silk Road Medical for $1.18 Billion
On Sept. 17, 2024, Boston Scientific announced the close of its acquisition of Silk Road Medical, a medical…
-
Lilly opened state-of-the-art research and development center in the Boston Seaport
On Aug. 13, 2024, Eli Lilly announced the opening of the Lilly Seaport Innovation Center (LSC), a research…
-
Moderna Received $176 million Award through BARDA to Accelerate Development of mRNA-based Pandemic Influenza Vaccine
On Jul. 2, 2024, Moderna announced a project award of $176 million through the Rapid Response Partnership Vehicle…
-
Moderna received U.S. FDA approval for RSV vaccine mRESVIA
On May 31, 2024, Moderna announced that the U.S. Food and Drug Administration (FDA) had approved mRESVIA (mRNA-1345),…
-
Eledon Pharma announced use of tegoprubart in first-ever transplant of genetically modified kidney from a pig to a human
On Mar. 21, 2024, Eledon Pharmaceuticals announced that tegoprubart, the company’s investigational anti-CD40L antibody, was used as a…
-
In a first, genetically edited pig kidney was transplanted into a human
On Mar. 21, 2024, Harvard Medical School physician-scientists at Massachusetts General Hospital announced they had successfully transplanted a…
-
Diagnostics | Disease | Medical Device | NIH | Oncology | Therapeutics | U.S. Congress
ARPA-H launched program for real-time drug delivery and disease tracking to improve patient self-care
On Sept. 26, 2023, the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department…
-
Biotechnology | Disease | FDA | Neurology | Therapeutics
FDA granted traditional approval for LEQEMBI (lecanemab-irmb) for the treatment of Alzheimer’s disease
On Jul. 6, 2023, Eisai and Biogen announced that the U.S. Food and Drug Administration (FDA) had approved the…
